Technical Analysis for VSTM - Verastem, Inc.

Grade Last Price % Change Price Change
grade F 1.33 2.31% 0.03
VSTM closed up 2.31 percent on Friday, September 20, 2019, on 53 percent of normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical VSTM trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
20 DMA Resistance Bearish 2.31%
Bollinger Band Squeeze Range Contraction 2.31%
Doji - Bullish? Reversal 2.31%
Fell Below 20 DMA Bearish 2.31%
Bollinger Band Squeeze Range Contraction 2.31%
NR7 Range Contraction 2.31%
BB Squeeze Started Range Contraction 2.31%

Older signals for VSTM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. The company's lead FAK inhibitor, VS-6063, is in Phase I/Ib testing in ovarian cancer, as well as developing for the treatment of mesothelioma and breast cancer. It is also developing FAK inhibitor VS-4718 and PI3K/mTOR inhibitor VS-5584 in patients with advanced cancers. The company's product candidates target CSCs that have been implicated in aggressive cancers, metastasis, and chemotherapeutic resistance. Verastem, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Medicine Biopharmaceutical Cancer Oncology Stem Cells Breast Cancer Ovarian Cancer Signal Transduction Cancer Research Metastasis Advanced Cancers Cancer Stem Cell Cancer Stem Cells Mesothelioma Mtor Phosphoinositide 3 Kinase
Is VSTM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.32
52 Week Low 1.16
Average Volume 992,778
200-Day Moving Average 2.3426
50-Day Moving Average 1.3546
20-Day Moving Average 1.3055
10-Day Moving Average 1.318
Average True Range 0.0718
ADX 12.96
+DI 20.1234
-DI 17.3965
Chandelier Exit (Long, 3 ATRs ) 1.2346
Chandelier Exit (Short, 3 ATRs ) 1.3954
Upper Bollinger Band 1.43
Lower Bollinger Band 1.181
Percent B (%b) 0.6
BandWidth 19.073152
MACD Line -0.0067
MACD Signal Line -0.0154
MACD Histogram 0.0087
Fundamentals Value
Market Cap 49.2 Million
Num Shares 37 Million
EPS -1.24
Price-to-Earnings (P/E) Ratio -1.07
Price-to-Sales 0.00
Price-to-Book 2.72
PEG Ratio -1.48
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.41
Resistance 3 (R3) 1.40 1.36 1.39
Resistance 2 (R2) 1.36 1.34 1.37 1.39
Resistance 1 (R1) 1.35 1.33 1.36 1.36 1.38
Pivot Point 1.31 1.31 1.32 1.32 1.31
Support 1 (S1) 1.30 1.29 1.31 1.31 1.28
Support 2 (S2) 1.26 1.28 1.27 1.27
Support 3 (S3) 1.25 1.26 1.27
Support 4 (S4) 1.26